For patients with asthma or COPD, PL554 has the potential to both reverse bronchodilation and reduce inflammation more quickly and with fewer adverse effects.
COPD Quiz: 8 GOLD Guideline Questions
Take this quick quiz to test your knowledge of the disease and the latest guidance for improving patient care.
Updated 2017 GOLD Recommendations for COPD
Important revisions to the GOLD recommendations include a new definition of COPD and refined diagnostic categories.
High Baseline CRP Predicts Mortality in COPD, Study Says
There are no optimal markers to predict mortality in COPD but results of a new study support further investigation of CRP.
COPD Morning Symptoms: Why Not a Treatment Goal?
A recent literature review found that up to 90% of COPD patients experience ADL-limiting morning symptoms.
Among Never-smokers, Black Women at Highest Risk for COPD
Results of a new study suggest that racial inequalities in COPD, especially in women, may be shaped by socioeconomic factors.
Prognostic Power of the BCSS in Severe COPD
The Breathlessness, Cough and Sputum Scale, used to evaluate COPD treatment efficacy, may help predict exacerbations in severe disease.
Symptom Clusters and Biomarkers in COPD
The CASCADE study found the biomarker of inflammation CRP associated with higher COPD symptom burden.
Amplified COPD Screening for Primary Care
A new 5-question COPD assessment tool may help identify more serious disease earlier in the primary care setting.
By clicking Accept, you agree to become a member of the UBM Medica Community.